EP Patent

EP3895700A2 — Pharmaceutical compositions comprising iron oxy-hydroxide

Assigned to Vifor Fresenius Medical Care Renal Pharma Ltd · Expires 2021-10-20 · 5y expired

What this patent protects

Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.

USPTO Abstract

Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.

Drugs covered by this patent

Patent Metadata

Patent number
EP3895700A2
Jurisdiction
EP
Classification
—
Expires
2021-10-20
Drug substance claim
No
Drug product claim
No
Assignee
Vifor Fresenius Medical Care Renal Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.